首页/数据集/NMR-based Metabolomics Analysis Predict Response to Neoadjuvant Chemotherapy for Triple Negative Breast Cancer

NMR-based Metabolomics Analysis Predict Response to Neoadjuvant Chemotherapy for Triple Negative Breast Cancer

Mendeley Data2026-04-09 收录

代谢标志物发现

三阴性乳腺癌疗效预测

数据链接：

https://data.mendeley.com/datasets/bbz8353xwh 数据链接链接失效反馈

官方服务：

资源简介：

Raw data of the "NMR-based Metabolomics Analysis Predict Response to Neoadjuvant Chemotherapy for Triple Negative Breast Cancer"

应用场景：

代谢标志物发现

心血管代谢疾病分型

Additional file 1: Figure S1. Flowchart for patient enrolment. Figure S2. Mass spectra of quality control (QC) samples. Figure S3. Density plots of the data. Figure S4. Pathway enrichment analysis of

Figshare2024-08-14 更新70

Interview in Canal Sur TV - Colon biomarkers

代谢标志物发现

结直肠癌研究

Interview in Canal Sur about the published article Serum nuclear magnetic resonance metabolomics analysis of human metastatic colorectal cancer: Biomarkers and pathway analysis (https://doi.org/10.100

Mendeley Data40

Raw data:Untargeted Metabolomics Analysis of Vaginal Secretion Reveals Potential Metabolic Biomarkers of Atrophic Vaginitis

代谢标志物发现

疾病诊断

In this study, we used untargeted metabolomics via liquid chromatography tandem mass spectrometry (LC-MS/MS) to analysis the differences in metabolic profiles of vaginal secretions between senile vagi

Figshare2023-11-16 更新30

Blood (POS) untargeted metabolomics raw data

代谢标志物发现

间质性膀胱炎病理研究

Metabolomic analyses of blood samples from 50 Hunner-type IC/BPS patients and 30 healthy controls were performed at Shanghai Applied Protein Technology Co. Ltd. (Shanghai, China). 100 µL of supernatan

Figshare2025-11-22 更新40

Table 1_Metabolomics reveals LysoPC a C17:0 (LPC 17:0) as candidate biomarker for personalized medicine in morbid obesity.xlsx

代谢标志物发现

病态肥胖个性化医疗

Morbid obesity represents the most severe form of obesity and is associated with increased cardiometabolic risk, including type 2 diabetes and cardiovascular complications. Current diagnostic approach

NIAID Data Ecosystem40

NMR-based Metabolomics Analysis Predict Response to Neoadjuvant Chemotherapy for Triple Negative Breast Cancer

资源简介：

相关数据集